Results 231 to 240 of about 8,991,947 (284)
Some of the next articles are maybe not open access.
Urology, 1975
Abstract Peyronie's disease is a localized fibrotic disorder involving the region adjacent to the erectile tissue of the penis. The pathogenesis, possible causes, and modes of therapy are fully discussed in this article. The urologist must consider the mental anguish often associated with this disease. Therefore, a plea is made to adopt an aggressive
Mark Immergut +3 more
openaire +3 more sources
Abstract Peyronie's disease is a localized fibrotic disorder involving the region adjacent to the erectile tissue of the penis. The pathogenesis, possible causes, and modes of therapy are fully discussed in this article. The urologist must consider the mental anguish often associated with this disease. Therefore, a plea is made to adopt an aggressive
Mark Immergut +3 more
openaire +3 more sources
Urologic Clinics of North America, 2001
Peyronie's disease remains one of the most perplexing diseases in urology. With continued basic research in wound healing and scarring, the understanding and management of this frustrating disease will improve. Initial treatment of Peyronie's disease should be conservative, with expectant therapy and medical management.
Shahram S. Gholami, Tom F. Lue
openaire +3 more sources
Peyronie's disease remains one of the most perplexing diseases in urology. With continued basic research in wound healing and scarring, the understanding and management of this frustrating disease will improve. Initial treatment of Peyronie's disease should be conservative, with expectant therapy and medical management.
Shahram S. Gholami, Tom F. Lue
openaire +3 more sources
Journal of Urology, 2019
PURPOSE Current penile traction therapy devices have significant limitations, including the need to use them for 3 to 8 hours per day. Given these issues, the novel RestoreX® penile traction therapy device was developed in cooperation with Mayo Clinic.
M. Ziegelmann +6 more
semanticscholar +1 more source
PURPOSE Current penile traction therapy devices have significant limitations, including the need to use them for 3 to 8 hours per day. Given these issues, the novel RestoreX® penile traction therapy device was developed in cooperation with Mayo Clinic.
M. Ziegelmann +6 more
semanticscholar +1 more source
The role of imaging in the diagnosis and management of Peyronie's disease.
Current Opinion in Urology, 2020PURPOSE OF REVIEW Several imaging modalities exist for the assessment of Peyronie's disease. However, comprehensive recommendations for using these objective modalities based on large-scale evidence-based studies do not yet exist.
M. Parmar, J. Masterson, T. Masterson
semanticscholar +1 more source
The management of Peyronie's disease [PDF]
BJU International, 2003 Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease. The medical management of chronic disease is futile as the delicate tunical architecture cannot regenerate. Surgical correction of the penile deformity is required in a
Suks Minhas, David Ralph
openaire +2 more sources
BJU International, 2018
To evaluate the efficacy and safety of a new penile traction device (PTD), ‘Penimaster PRO’, in a group of patients with stable Peyronie's disease (PD) compared with a non‐intervention group in a multicentre study.
I. Moncada +7 more
semanticscholar +1 more source
To evaluate the efficacy and safety of a new penile traction device (PTD), ‘Penimaster PRO’, in a group of patients with stable Peyronie's disease (PD) compared with a non‐intervention group in a multicentre study.
I. Moncada +7 more
semanticscholar +1 more source
2013
Peyronie’s disease (PD) is a benign disease of the penis of unknown cause. First fully described almost 300 years ago by François de La Peyronie, although “nodus penis” has been already described centuries before by Fallopius and Vesalius (Fornara and Gerbershagen 2004).
Pietro Pavlica +4 more
openaire +3 more sources
Peyronie’s disease (PD) is a benign disease of the penis of unknown cause. First fully described almost 300 years ago by François de La Peyronie, although “nodus penis” has been already described centuries before by Fallopius and Vesalius (Fornara and Gerbershagen 2004).
Pietro Pavlica +4 more
openaire +3 more sources
Journal of the American Geriatrics Society, 1971
AbstractPeyronie's disease, a penile deformity of the mature male, is distressing but not necessarily permanent. The initial inflammatory infiltrate does not always progress to irreversible fibrosis. Although spontaneous resolution sometimes occurs, resolution can be hastened and rendered more likely by anti‐inflammatory measures such as cortisone and ...
openaire +3 more sources
AbstractPeyronie's disease, a penile deformity of the mature male, is distressing but not necessarily permanent. The initial inflammatory infiltrate does not always progress to irreversible fibrosis. Although spontaneous resolution sometimes occurs, resolution can be hastened and rendered more likely by anti‐inflammatory measures such as cortisone and ...
openaire +3 more sources
Journal of Urology, 2019
Purpose: In a multi-institutional setting we studied the efficacy and safety outcomes at multiple high volume centers where collagenase Clostridium histolyticum is used to treat Peyronie's disease.
W. Hellstrom +8 more
semanticscholar +1 more source
Purpose: In a multi-institutional setting we studied the efficacy and safety outcomes at multiple high volume centers where collagenase Clostridium histolyticum is used to treat Peyronie's disease.
W. Hellstrom +8 more
semanticscholar +1 more source
Implant Surgery in Peyronie’s Disease
Urologia Internationalis, 1997The etiology and evolution of Peyronie's disease are not well known, and this certainly affects patient management. If spontaneous regression or stabilization of the disease is lacking, actually all therapies, except surgery, seem to be only partially successful.
Marzi, M +4 more
openaire +5 more sources